PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

HomepageArkemaarkema-presentation-ArrMaz

arkema-presentation-ArrMaz

Arkema

Browse presentations, reports, and documents from Arkema.

Tags

2019

Filter options

All (38)●
earnings (1)○
earnings_deck (4)○
investor_presentation (3)○
presentation (30)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

This presentation outlines Arkema's proposed acquisition of ArrMaz, highlighting strategic fit and growth in specialty surfactants.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Arkema

2024_Corporate_presentation

presentation

4-5-t-moignage-arkema-b4c-cbe-2024c-le-12-mars-2024-rouen-pdf-10449

presentation

Similar presentations from other companies

Luxfer Holdings_January_2021_641_64641

presentation

Luxfer Holdings

McCann_FitzGerald_-_2023_and_2024_Review_and_Horizon_Scan_-_Finance_and_Financial_Services_-_Slides

presentation

McCann Fitzgerald

arkema-presentation-ArrMaz - Arkema | Presentation Nation

Arkema 2022 Roadshow Presentation

investor_presentation

investor_presentation

40 Pages

arkema-acquisition-project-bostik-presentation

presentation

Arkema-Becancour-Battery-Site-Tour

presentation

ARKEMA_CMD%202023_version%20definitive%2026.09.2023

presentation

2022-5-19-Kinwong-Company-Presentation-General-Rev.01

presentation

Kinwong

Erste Group__2023__611_91611

presentation

Erste Group

Q4-FY22-Earnings-Presentation

presentation

Rossari Biotech Limited

ATI-Advisory-PY2024-Nonmedical-Supplemental-Benefits-Chartbook

presentation

ATI Advisory